Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-25 @ 2:33 PM
Study NCT ID:
NCT05357950
Status:
COMPLETED
Last Update Posted:
2025-09-05
First Post:
2022-04-27
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety, Tolerability and Efficacy of PrimeC in Subjects With ALS
Sponsor:
NeuroSense Therapeutics Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-04
Completion Date Type:
ACTUAL
First Submit Date:
2022-04-27
First Submit QC Date:
None
Study First Post Date:
2022-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-29
Last Update Post Date:
2025-09-05
Last Update Post Date Type:
ESTIMATED